Skip to main content
. 2017 Jul 19;7:5925. doi: 10.1038/s41598-017-06132-z

Figure 6.

Figure 6

The nuclear factor kappaB (NF-κB) pathway contributed to CEP55-mediated aggressiveness and tumourigenicity of pancreatic cancer (PANC) cells in vitro and in vivo. (a) The protein expression of IκBα transfected into CEP55-overexpressing PANC cells is detected by western blotting assay. (b) MTT assay of CEP55-overexpressing SW1990 and Capan-1 cells transduced with IκBα or JSH-23. (c) Quantification of crystal violet-stained colonies of CEP55-overexpressing SW1990 and Capan-1 cells transduced with IκBα or JSH-23 after 14 days of colony formation. (d) Wound-healing assay assessment of CEP55-overexpressing SW1990 and Capan-1 cell migration after transfection with IκBα or JSH-23. (e) Quantification of CEP55-overexpressing SW1990 and Capan-1 cell invasion in a Transwell matrix penetration assay. The quantification of invaded cells represents the mean of three independent experiments. (f) Subcutaneous tumour xenograft model in nude mice; representative images of the tumours formed by CEP55-overexpressing Capan-1 cells transfected with IκBα (left panel, n = 5). Growth curves for tumour formation after implantation of CEP55-overexpressing Capan-1 cells transfected with IκBα (right panel). Bars represent the mean ± SD of three independent experiments. *P < 0.05.